Literature DB >> 9169041

Molecular characterization of a complex chromosomal rearrangement in a pleomorphic salivary gland adenoma involving the 3'-UTR of HMGIC.

J M Geurts1, E F Schoenmakers, W J Van de Ven.   

Abstract

Recently, the high mobility group protein gene, HMGIC, was identified as a common genetic denominator in benign tumors with chromosome 12q13-15 aberrations, such as lipomas, uterine leiomyomas, pleomorphic adenoma of the salivary glands, hamartomas of breast and lung, angiomyxomas, and endometrial polyps. In most cases, the rearrangements resulted in the separation of the three HMGIC DNA-binding motifs from the acidic carboxy-terminal tail. Here, we report about the molecular characterization of a case of pleomorphic adenoma carrying a t(1;12)(p22;q15). Studies were performed on a cell line derived from the primary tumor, i.e., cell line Ad-312/SV40. Although the chromosome 12 breakpoint was initially mapped more than 1 Mb distal to the HMGIC gene by fluorescence in situ hybridization (FISH) analysis, the present molecular studies reveal a more complex chromosomal rearrangement that directly affects the HMGIC gene. Using 3'-RACE analysis, a HMGIC fusion transcript was detected that contained the complete HMGIC, coding region but lacked the putative mRNA destabilizing AUUUA motifs that are normally present in the 3'-UTR of HMGIC. Wild-type HMGIC transcripts were also detected in the tumor cells. The results suggest that alterations in the 3'-noncoding region of HMGIC may have to be considered as pathogenetically relevant.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9169041     DOI: 10.1016/s0165-4608(96)00411-6

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  14 in total

1.  Misexpression of wild-type and truncated isoforms of the high-mobility group I proteins HMGI-C and HMGI(Y) in uterine leiomyomas.

Authors:  M Klotzbücher; A Wasserfall; U Fuhrmann
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

2.  Overexpression of HMGA2 promotes metastasis and impacts survival of colorectal cancers.

Authors:  Xiaochen Wang; Xiyong Liu; Angela Ying-Jian Li; Lirong Chen; Lily Lai; Her Helen Lin; Shuya Hu; Lifang Yao; Jiaping Peng; Sofia Loera; Lijun Xue; Bingsen Zhou; Lun Zhou; Shu Zheng; Peiguo Chu; Suzhan Zhang; David Kong Ann; Yun Yen
Journal:  Clin Cancer Res       Date:  2011-01-20       Impact factor: 12.531

3.  The tumor suppressor microRNA let-7 represses the HMGA2 oncogene.

Authors:  Yong Sun Lee; Anindya Dutta
Journal:  Genes Dev       Date:  2007-04-16       Impact factor: 11.361

4.  Induction of a novel cellular homolog of interleukin-10, AK155, by transformation of T lymphocytes with herpesvirus saimiri.

Authors:  A Knappe; S Hör; S Wittmann; H Fickenscher
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

5.  Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation.

Authors:  Christine Mayr; Michael T Hemann; David P Bartel
Journal:  Science       Date:  2007-02-22       Impact factor: 47.728

6.  [Molecular markers in salivary gland tumors: their use in diagnostic and prognostic workup].

Authors:  A Fehr; G Stenman; J Bullerdiek; T Löning
Journal:  Pathologe       Date:  2009-11       Impact factor: 1.011

7.  A novel truncated form of HMGA2 in tumors of the ovaries.

Authors:  Antonio Agostini; Ioannis Panagopoulos; Ben Davidson; Claes Goran Trope; Sverre Heim; Francesca Micci
Journal:  Oncol Lett       Date:  2016-06-29       Impact factor: 2.967

8.  High mobility group A2 protein and its derivatives bind a specific region of the promoter of DNA repair gene ERCC1 and modulate its activity.

Authors:  Lars Borrmann; Ralf Schwanbeck; Tomasz Heyduk; Birte Seebeck; Piere Rogalla; Jörn Bullerdiek; Jacek R Wisniewski
Journal:  Nucleic Acids Res       Date:  2003-12-01       Impact factor: 16.971

9.  Expression levels of HMGA2 in adipocytic tumors correlate with morphologic and cytogenetic subgroups.

Authors:  Hammurabi Bartuma; Ioannis Panagopoulos; Anna Collin; Domenico Trombetta; Henryk A Domanski; Nils Mandahl; Fredrik Mertens
Journal:  Mol Cancer       Date:  2009-06-09       Impact factor: 27.401

10.  Oncocytic change in pleomorphic adenoma: molecular evidence in support of an origin in neoplastic cells.

Authors:  Silvana Di Palma; Maryou B K Lambros; Kay Savage; Chris Jones; Alan Mackay; Tim Dexter; Marjan Iravani; Kerry Fenwick; Alan Ashworth; Jorge S Reis-Filho
Journal:  J Clin Pathol       Date:  2006-02-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.